top of page



Publications and Other News

Koirala, M., DiPaola, M. Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment. Biomedicines 2024, 12, 1801
Koirala, M., DiPaola, M. Targeting CDK9 in Cancer: An Integrated Approach of Combining In-Silico Screening with Experimental Validation for Novel Degraders. Curr. Issues Mol. Biol. 2024, 46, 1713-1730.
Mario DiPaola: Creating Legacy in Biotechnology and Pharmaceuticals. World's Leaders 2023
Mario DiPaola: Who's Who of Top Executives
Therabene Inc. Announces Positive Preclinical Results for Two Promising New Degrader Molecules in Collaboration with Biocytogen. First World Pharma, 2024
bottom of page